If a doctor has raised the possibility of an antidepressant for your teen, you have probably also heard about the "black box warning" — and felt a jolt of worry. This page explains, at a plain and balanced level, what SSRIs are, what that warning actually means, and why the decision belongs in a careful conversation with a prescriber rather than in a moment of fear. It is information, not medical advice for your child.
What it is
SSRIs — selective serotonin reuptake inhibitors — are a widely used class of antidepressant medication. They are most commonly prescribed for depression and for anxiety disorders, and they work on serotonin, one of the chemical messengers in the brain involved in mood. They are not sedatives or quick fixes; they typically take some weeks of regular use before their full effect is clear.
The "black box warning" is the U.S. Food and Drug Administration's most serious type of medication labeling. For antidepressants, it flags an increased risk of suicidal thinking and behavior in children, adolescents, and young adults during early treatment. It is important to read that carefully: the warning concerns suicidal thoughts and behaviors, and the data behind it did not show an increase in completed suicides. The warning exists to prompt close monitoring, not to declare these medications off-limits for young people.
This page describes SSRIs and the warning in general terms only. Which medication, if any, is appropriate for a given teen, and how it is started and monitored, are decisions for a prescriber who knows the whole clinical picture. We do not offer dosing guidance, and nothing here should be used to start, stop, or change a medication on your own.
How it shows up in teens
When an SSRI is part of a teen's care, prescribers generally start carefully and watch closely, especially in the first weeks and after any change. Families are usually asked to be part of that monitoring — staying alert to changes in mood or behavior, new or worsening agitation, and any emergence of suicidal thoughts, and staying in regular contact with the prescriber.
Like any medication, SSRIs can have side effects. These are often mild and tend to ease over time, but they vary from person to person, and some can be more significant. The practical point for parents is to keep an open line with the prescriber, report concerning changes promptly, and not adjust or discontinue the medication without medical guidance, since stopping abruptly can cause its own problems.
It also helps to set expectations with your teen. SSRIs are not instant, and a slow, partial improvement is common before things feel clearly better. Knowing this in advance can prevent discouragement during the early weeks.
What the evidence says about treatment
The balanced, mainstream view is that for many young people with moderate to severe depression or significant anxiety, the potential benefits of an appropriately chosen and monitored SSRI can outweigh the risks — particularly when untreated depression itself carries serious dangers, including suicide. The black box warning is best understood as a reason for vigilance and good monitoring, not as a verdict that these medications are unsafe for teens.
Evidence generally supports an individualized approach, often pairing medication with psychotherapy such as CBT or IPT-A rather than relying on medication alone. The right plan depends on the severity of the illness, the specific diagnosis, prior treatment, and your teen's own situation and preferences.
The honest bottom line is that this is a genuine risk-benefit decision with no one-size-fits-all answer. A good prescriber will walk you and your teen through the reasoning, explain the monitoring plan, and revisit the decision as you go. That conversation — not a website, and not the warning label alone — is where the choice should be made.
Where to find help
Medication for a teen is typically prescribed and managed by a child and adolescent psychiatrist or, in some cases, a pediatrician or primary care provider comfortable with these treatments. If you have questions or concerns about an SSRI, the prescriber is the right first call.
For reliable background, the U.S. Food and Drug Administration (FDA), the National Institute of Mental Health (NIMH), and the American Academy of Child & Adolescent Psychiatry (AACAP) all publish information for families about antidepressants and the black box warning. Our Find Help directory can help you locate care by state and level of need.
If your teen is in crisis or having thoughts of suicide — whether or not they are taking medication — reach the 988 Suicide & Crisis Lifeline any time by call or text at 988, or text HOME to 741741. In an immediate emergency, call 911 or go to the nearest emergency room.
Sources
- U.S. Food and Drug Administration (FDA) — fda.gov
- National Institute of Mental Health (NIMH) — nimh.nih.gov
- American Academy of Child & Adolescent Psychiatry (AACAP) — aacap.org
- 988 Suicide & Crisis Lifeline — 988lifeline.org
- [Pending clinical review — formal citations to be added by the reviewer. See medical review.]